<--- Back to Details
First PageDocument Content
Cancer organizations / Pharmacology / Kidney cancer / Bevacizumab / National Cancer Institute / Clinical trial / Investigational New Drug / Renal cell carcinoma / Sunitinib / Medicine / Health / Food and Drug Administration
Date: 2008-05-28 21:39:37
Cancer organizations
Pharmacology
Kidney cancer
Bevacizumab
National Cancer Institute
Clinical trial
Investigational New Drug
Renal cell carcinoma
Sunitinib
Medicine
Health
Food and Drug Administration

Add to Reading List

Source URL: ctep.cancer.gov

Download Document from Source Website

File Size: 516,32 KB

Share Document on Facebook

Similar Documents

Health / Food and Drug Administration / Medicine / Pharmaceutical industry / Epidemiology / Medical statistics / Clinical trials / Accelerated approval / Surrogate endpoint / New drug application / Bevacizumab / Fast track

United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate

DocID: 1riEa - View Document

Clinical medicine / Medicine / Cancer / Cancer treatments / RTT / Brain tumor / Bevacizumab / Glioblastoma / Head and neck cancer / Temozolomide / Adjuvant therapy / Chemotherapy

Lettre d’information du réseau GCO - Spéciale ASCOLes Groupes Coopérateurs en Oncologie à l’ASCO 2016 Les Groupes Coopérateurs en Oncologie (GCO) seront représentés au 52ème congrès de l’ASCO (Ameri

DocID: 1qX2r - View Document

Clinical medicine / Cancer / Medicine / Cancer treatments / Organofluorides / Angiogenesis inhibitors / Eli Lilly and Company / Bevacizumab / FOLFIRI / FOLFOXIRI / Chemotherapy regimen / Cetuximab

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

DocID: 1qSc2 - View Document

Clinical medicine / Cancer / Health / Clinical Lung Cancer / Lung cancer / SWOG / Bevacizumab / Nicholas J. Vogelzang / Draft:Alexandros Makriyannis

CURRICULUM VITAE Mary W. Redman, Ph.D. Current Address:

DocID: 1qCPH - View Document

Bevacizumab / Brain tumor / Cancer treatments / Glioblastoma multiforme / Chemotherapy / Reolysin / Ranibizumab

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

DocID: 1pDeC - View Document